For example, miR-9-5p, which is decreased in AD patients [73], inhibits amyloid-β (Aβ)-induced spine loss and Tau phosphorylation by inhibiting the expression of calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) [74]. This evidence concerns the gene MAPT and Alzheimer disease.